The Lancet · 2015 · 175 citations · 20 references
Neurological DisorderMedicineClinical TrialsTreatment OptionPharmacotherapyNeurologyNon-inferiority TrialMultiple SclerosisNeuroimmunology
20
Rating neurologic impairment in multiple sclerosis
John F. Kurtzke · Neurology · 1983 · 14.7K citations
Defining the clinical course of multiple sclerosis
Fred Lublin, Stephen C. Reingold, Jeffrey A. Cohen et al. · Neurology · 2014 · 3K citations · Full text
Neuroimaging Biomarkers, Scleroderma, Neurological Disease +15
Evidence for a two-stage disability progression in multiple sclerosis
Emmanuelle Leray, Jacqueline Yaouanq, Emmanuelle Le Page et al. · Brain · 2010 · 578 citations · Full text
Tattersall Rb · The Lancet · 1972 · 433 citations
Effect of relapses on development of residual deficit in multiple sclerosis
Fred Lublin, Monika Baier, Gary Cutter · Neurology · 2003 · 419 citations